Nemaura Medical Inc.

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Nemaura Medical develops affordable diagnostic and digital tools for a range of medical conditions, focusing on non-invasive microsystems for measuring blood markers at the skin's surface.

NASDAQ:NMRD

Nemaura Medical

Market Cap

1.34M

Beta: −0.06

Volume Today

1K

Avg: 35.11K

PE Ratio

−0.38

PFCF: −0.26

Analysis Not Available